Full-Time

Accountant

Viome Life Sciences

Viome Life Sciences

51-200 employees

Personalized nutrition via microbiome tests

Compensation Overview

$80k - $100k/yr

Bellevue, WA, USA

In Person

Bachelor's

Category
Accounting (1)
Required Skills
NetSuite
Microsoft Office
QuickBooks
Financial analysis
Excel/Numbers/Sheets

Get referred to Viome Life Sciences

See people who can refer or advise you

Requirements
  • A Bachelor of Arts or Bachelor of Science degree majoring in Accounting or a related field.
  • Proficiency with Microsoft Office, with strong Excel skills.
  • General knowledge of Generally Accepted Accounting Principles.
  • Detail-oriented and accurate data-entry skills.
  • Clear oral and written communication skills.
  • Ability to maintain confidentiality and a high level of integrity.
Responsibilities
  • Set up, review, and pay vendors and miscellaneous office expense bills.
  • Book and reconcile bank transactions, and communicate with banks and vendors to resolve issues and discrepancies.
  • Manage, book, and reconcile business credit-card transactions, and collect receipts from account managers.
  • Review and process employee travel expenses.
  • Receive and reconcile customer payments and other payments.
  • Prepare journal entries and perform account reconciliations in QuickBooks.
  • Assist with invoice processing and collections.
  • Assist in preparing financial reports.
  • Assist with maintaining internal financial controls and procedures.
  • Assist with developing and updating accounting processes.
  • Assist with annual auditing and ad hoc projects.
  • Perform other job duties as assigned.
Desired Qualifications
  • Experience with QuickBooks or NetSuite.
  • Five to seven years of accounting-related experience.

Viome Life Sciences offers personalized nutrition and gut-health solutions by analyzing the microbiome and cellular health through health tests. Using mRNA technology and AI, it translates these results into individualized diet plans and supplement recommendations, including probiotics. Revenue comes from selling health tests, personalized supplements, and probiotic subscriptions. Its edge lies in combining microbiome data with cellular insights and applying AI-driven, ongoing personalized wellness guidance to help people optimize health.

Company Size

51-200

Company Stage

Series D

Total Funding

$214M

Headquarters

Bellevue, Washington

Founded

2016

Get referred to Viome Life Sciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ezaki Glico plans 50,000 Japan customers by 2030, expanding Viome's dataset fast.
  • Microsoft Azure integration, announced July 7, 2025, strengthens scalable, HIPAA-compliant cloud operations.
  • Circulate acquisition on August 12, 2026 opens 400-site plasma-exchange distribution beyond 40 clinics.

What critics are saying

  • NAD ordered Viome to drop comparative cancer-diagnosis claims on March 24, 2026.
  • Published reviews still question outcome validity; personalized food lists lack hard-endpoint evidence.
  • If trust cracks, Viome's subscription and supplement engine faces a fast demand collapse.

What makes Viome Life Sciences unique

  • Viome uses metatranscriptomic RNA, not static DNA, to score active gut biology.
  • Ezaki Glico partnership proves Viome's partner-led rollout model enters Japan on 2026-09-14.
  • NAD upheld CancerDetect biomarker claims March 24, 2026, supporting differentiated cancer-detection credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

1%
Yahoo Finance
Sep 14th, 2026
Viome enters Japan with Ezaki Glico to launch precision health service based on gut bacteria mRNA analysis

Viome Life Sciences has partnered with Japan's Ezaki Glico to launch mRNA HEALTH TRACKER®, Japan's first personalised health service based on gut bacteria mRNA analysis. The collaboration marks Viome's entry into the Japanese market. Founded in 1922, Ezaki Glico is a century-old Japanese food company. The service uses Viome's testing kits to analyse microbiome data, generating 26 personalised health scores and food recommendations. Glico's personal advisers then guide customers towards suitable foods and supplements. This represents the first international application of Viome's partnership model. Under this approach, Viome provides testing technology, RNA analysis, and AI models, whilst partners contribute product formulation, distribution, and consumer guidance. The platform improves accuracy as customers act on recommendations and retest over time.

GeekWire
Aug 12th, 2026
Seattle longevity startups merge: Viome acquires plasma exchange pioneer Circulate Health for $15M–$50M

Seattle-area longevity startups Viome Life Science and Circulate Health are merging. Viome acquired Circulate for between $15 million and $50 million, though specifics were not disclosed. Viome sells at-home test kits for saliva, blood, and stool samples, offering personalised supplements based on results. It has also developed RNA biomarker diagnostics, including an oral and throat cancer test with FDA breakthrough designation. Circulate provides therapeutic plasma exchange services through specially trained nurses, aiming to remove inflammatory factors and aging-associated compounds from blood. The combined company has 115 full-time employees and 10 consultants. Most Circulate staff retained their positions. The merger could expand their reach from 40 clinics to 400 sites. Circulate raised $14 million before acquisition. Viome, founded a decade ago, has raised approximately $250 million. Both microbiome testing and plasma exchange face questions regarding scientific evidence supporting their health benefit claims.

The Healthcare Technology Report
Jul 18th, 2025
Viome Partners with Microsoft to Advance Preventive Healthcare Using RNA and AI

Viome will integrate its extensive dataset of human and microbial gene expression with Microsoft Azure's secure and scalable infrastructure services, including Ultra Disk Storage and Virtual Machines.

WisdomInterface
Apr 14th, 2025
Viome Launches AI-Powered Full Body Intelligence(TM) Test To Help You Stay Healthy, Slow Aging, and Make Illness Optional

BELLEVUE, Wash., April 14, 2025 /PRNewswire/ - Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its most transformative consumer product, redefining how individuals understand, track, and improve their health through evolving biological insights.

PR Newswire
Apr 14th, 2025
Viome Launches Ai-Powered Full Body Intelligence™ Test To Help You Stay Healthy, Slow Aging, And Make Illness Optional

Viome's Full Body Intelligence Test™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening but why , and turns those insights into personalized daily nutrition advice to help you live healthier and longer., and turns those insights into personalized daily nutrition advice to help you live healthier and longer. Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health conditions.BELLEVUE, Wash., April 14, 2025 /PRNewswire/ -- Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its most transformative consumer product, redefining how individuals understand, track, and improve their health through evolving biological insights.Viome Launches AI-Powered Full Body Intelligence™ Test To Help You Stay Healthy, Slow Aging, and Make Illness OptionalAt the core of Viome's new experience is the radical idea that your genes are not your destiny, and your health outcomes are not static or predestined but measurable, modifiable, and within your control. Viome is the only company in the world that uses advanced RNA sequencing to decode your body's active gene expression and applies AI to translate that data into practical, daily health guidance. This includes what to eat, what to avoid, why you should eat certain foods, and how your personal health insights are connected to the most common diseases."Our medical industrial complex is reactive and waits until we experience symptoms or develop a disease instead of helping us stay healthy in the first place," said Naveen Jain, Founder and CEO of Viome. "Symptoms that we feel are the body's last cry for help